Business Description
Hims & Hers Health Inc
ISIN : US4330001060
Share Class Description:
XSWX:HIMS: Ordinary Shares - Class ATotal Employee Number:
2,442Compare
Compare
Traded in other countries / regions
HIMS.USAHIMS.Mexico82W.Germany IPO Date
2026-07-01Description
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.66 | |||||
Equity-to-Asset | 0.2 | |||||
Debt-to-Equity | 2.54 | |||||
Debt-to-EBITDA | 30.13 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 3.9 | |||||
Beneish M-Score | 11.03 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 52.2 | |||||
3-Year Book Growth Rate | 16.7 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 18.43 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.69 | |||||
Quick Ratio | 1.56 | |||||
Cash Ratio | 1.21 | |||||
Days Inventory | 52.61 | |||||
Days Sales Outstanding | 7.29 | |||||
Days Payable | 93.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.9 | |||||
Shareholder Yield % | -12.67 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 71.72 | |||||
Operating Margin % | -1.29 | |||||
Net Margin % | -0.56 | |||||
EBITDA Margin % | 1.59 | |||||
ROE % | -2.47 | |||||
ROA % | -0.7 | |||||
ROIC % | -0.94 | |||||
3-Year ROIIC % | 12.72 | |||||
ROC (Joel Greenblatt) % | -8.37 | |||||
ROCE % | -2.07 | |||||
Years of Profitability over Past 10-Year | 2 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 3.87 | |||||
PB Ratio | 19.03 | |||||
Price-to-Free-Cash-Flow | 135.79 | |||||
Price-to-Operating-Cash-Flow | 32.14 | |||||
EV-to-EBIT | -290.74 | |||||
EV-to-EBITDA | 236.85 | |||||
EV-to-Revenue | 3.76 | |||||
EV-to-FCF | 147.34 | |||||
Price-to-GF-Value | 0.94 | |||||
Price-to-Projected-FCF | 8.29 | |||||
Earnings Yield (Greenblatt) % | -0.34 | |||||
FCF Yield % | 0.71 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hims & Hers Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil CHF) | |||
| EPS (TTM) (CHF) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (CHF) | - | ||
| 20-Day SMA (CHF) | - | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (CHF) | 30.49 - 30.49 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hims & Hers Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hims & Hers Health Inc Stock Events
| Event | Date | Price (CHF) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-03 17:00 | In 124 days | ||
| Third quarter earnings results for 2026 | 2026-11-03 | In 123 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-04 17:00 | In 33 days | ||
| Second quarter earnings results for 2026 | 2026-08-04 | In 32 days | ||
| General meeting for 2026 | 2026-06-11 11:00 | -- | ||
| First quarter earnings conference call for 2026 | 2026-05-11 17:00 | -- | ||
| First quarter earnings results for 2026 | 2026-05-11 | -- | ||
| Morgan Stanley Technology, Media & Telecom Conference | 2026-03-02 | -- | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-23 17:00 | -- | ||
| Annual report for 2025 | 2026-02-23 | -- |
Show
Entries
Hims & Hers Health Inc Frequently Asked Questions
What is Hims & Hers Health Inc(XSWX:HIMS)'s stock price today?
The current price of XSWX:HIMS is CHF30.49. The 52 week high of XSWX:HIMS is CHF30.49 and 52 week low is CHF30.49.
When is next earnings date of Hims & Hers Health Inc(XSWX:HIMS)?
The next earnings date of Hims & Hers Health Inc(XSWX:HIMS) is 2026-08-04 Est..
Does Hims & Hers Health Inc(XSWX:HIMS) pay dividends? If so, how much?
Hims & Hers Health Inc(XSWX:HIMS) does not pay dividend.
Press Release
Articles on Hims & Hers Health Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers